Among them, one focused on the prognostic value of linc00152 expression on cancer relapse (HR = 3.56, 95% CI: 1.59–7.97), and another one explored the association between linc00152 and tumor progression (HR = 3.43, 95% CI: 1.10–10.69). The gene discussed is CYTOR; the disease is neoplasm.